Research Article
Extended Use of The Spanner® Temporary Prostatic Stent in Catheter-Dependent Men with Comorbidities
Table 6
PVR summary for patients in the Continuing Access Program.
| | PVR category | n (%) | | Visit 1 (n = 10) | Visit 2 (n = 9) | Visit 3 (n = 9) | Visit 4 (n = 7) | Visit 5 (n = 6) | Visit 6 (n = 5) | Visit 7 (n = 5) | Visit 8 (n = 2) |
| | PVR ≤ 150 ml | 10 (100%) | 8 (89%) | 7 (78%) | 6 (86%) | 5 (83%) | 4 (80%) | 4 (80%) | 1 (50%) | | PVR 151–250 ml | 0% | 1 (11%) | 1 (11%) | 1 (14%) | 1 (17%) | 1 (20%) | 0% | 0% | | PVR > 250 ml | 0% | 0% | 1 (11%) | 0% | 0% | 0% | 1 (20%) | 1 (50%) |
|
|
Stratification of all enrolled CAP patients by PVR volume category with The Spanner in situ.
|
